Skip to main content
Doseology Sciences Inc. logo

Doseology Sciences Inc. — Investor Relations & Filings

Ticker · MOOD ISIN · CA2584842033 LEI · 984500E473NF654A0619 CSE Manufacturing
Open in API
Filings indexed 119 across all filing types
Latest filing 2026-03-30 Regulatory Filings
Country CA Canada
Listing CSE MOOD

About Doseology Sciences Inc.

https://doseology.com

Doseology Sciences Inc. is a performance-driven innovation company operating at the intersection of biotechnology and advanced delivery systems. The company is focused on establishing a leadership position within the rapidly emerging oral stimulant pouch category. Doseology engineers precision-formulated, science-backed stimulant pouches, utilizing proprietary intellectual property and disruptive ingredients to create better-for-you consumer products. While expanding its portfolio of oral stimulants, such as caffeine-based energy pouches, the company also maintains a focus on the research, development, and sale of functional mushroom products through its subsidiary, Dose Labs Inc., often targeting mental health therapies.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2, a CEO certification of interim filings under Canadian NI 52-109 for a venture issuer. It is not the interim report itself (IR) nor a management discussion & analysis (MDA) or an earnings release (ER). It is a short regulatory compliance certificate required by securities legislation, fitting best as a general regulatory filing rather than a substantive report. Therefore, it should be classified under Regulatory Filings (RNS).
2026-03-30 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing Kidoz’s strategic positioning and platform capabilities—there is no detailed financial data (so not an ER, IR, or AR), no notice of dividend, no board changes, no voting results, no share transactions, no M&A, and no report attachment. It is essentially a general company newswire release that does not fit any specific category, making it a fallback regulatory announcement.
2026-03-30 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing a pilot production run of a new product (caffeine-based energy pouches) under the Feed That Brain® brand. It does not contain financial results (so it is not an Earnings Release), it is not an investor presentation, nor is it a regulatory capital, dividend, or governance filing. It is a general announcement of business developments and forward-looking statements. Since it does not fit any other specific category, it should be classified under the fallback category for miscellaneous regulatory announcements: RNS.
2026-01-21 English
News release - English.pdf
Report Publication Announcement Classification · 1% confidence The document is a press release announcing that the company has filed its Annual Information Form (AIF) on SEDAR+. It explicitly states that the purpose of the release is to inform investors of the filing and provides a link to where the document can be accessed. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore falls under the Report Publication Announcement (RPA) category.
2026-01-16 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Doseology Sciences Inc. announcing a strategic partnership with McKinney Regulatory Science Advisors to assist with regulatory submissions and product development. It does not fit into specific categories like financial reports, dividend announcements, or board changes. As it is a general corporate announcement regarding business operations and strategy, it falls under the 'Regulatory Filings' (RNS) category as a catch-all for miscellaneous corporate news.
2026-01-12 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109FV2 Certification of Interim Filings', which is an officer certification/attestation document. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference other reports like interim filings. It does not contain the actual financial statements or substantive financial data required for an Interim Report (IR) classification. 9M 2025
2025-11-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.